FDA Advocacy & Resources| Friends of Cancer Research

Conference on Clinical Cancer Research Update

Appropriations Update

Download Friends Documents

Download Our 2010 Annual Report

FDA Advocacy & Resources

FDA and Cancer Research

As NIH and NCI funded medical research continues to develop scientific advances, the Food and Drug Administration (FDA) serves as the nexus between new discoveries and routine cancer care. Without a well-funded and scientifically rigorous FDA this process will become bottle-necked.

Developing new oncology products involves multiple centers at FDA that regulate drugs, biologics, imaging agents, diagnostics and devices that are the future of cancer research
Providing FDA the resources that it needs to be scientifically rigorous will help ensure product safety and efficacy.
Without sufficient resources the FDA will not be able to keep pace. For millions of patients, this means a stalled pipeline of life-saving products.

FDA Advocacy and Resource Documents:

BNA- Speakers Say FDA Cannot Fulfill Mission Without Additional Resources, Collaboration

BY JOHN T. AQUINO, The Food and Drug Administration is underresourced and cannot fulfill its mission as a safety organization grounded in cutting-edge science until it receives more funding
Read more...

Inside Health Policy- FDA Eyes Setting Up Two CER Centers To Leverage Agency Data

In order to leverage pre-approval and post-market data collected by FDA to advance comparative effectiveness research and personalized medicine,
Read more...